LoginSignup
SWA

Shockwave Med

Stock
Stock
ISIN: US82489T1043
Ticker: SWAV
US82489T1043
SWAV

Price

Price

Frequently asked questions

What is Shockwave Med's market capitalization?

The market capitalization of Shockwave Med is $12.57B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Shockwave Med's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Shockwave Med is 78.45. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Shockwave Med?

Shockwave Med's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $4.267. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Shockwave Med's stock?

Currently, 10 analysts cover Shockwave Med's stock, with a consensus target price of $321.25. Analyst ratings provide insights into the stock's expected performance.

What is Shockwave Med's revenue over the trailing twelve months?

Over the trailing twelve months, Shockwave Med reported a revenue of $787.97M.

What is the EBITDA for Shockwave Med?

Shockwave Med's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $173.45M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Shockwave Med?

Shockwave Med has a free cash flow of $166.14M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Shockwave Med's stock?

The 5-year beta for Shockwave Med is 1.07. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Shockwave Med have, and what sector and industry does it belong to?

Shockwave Med employs approximately 1,468 people. It operates in the Health Care sector, specifically within the Medical Equipment & Supplies industry.

Financials

Market Cap

 $12.57B

5Y beta

 1.07

EPS (TTM)

 $4.267

P/E ratio (TTM)

 78.45

Revenue (TTM)

 $787.97M

EBITDA (TTM)

 $173.45M

Free Cashflow (TTM)

 $166.14M

Pricing

52W span
$146.91$363.14

Analyst Ratings

The price target is $321.25 and the stock is covered by 10 analysts.

Buy

0

Hold

10

Sell

0

Information

Shockwave Medical, Inc. is a medical device company. The Company is primarily engaged in the development and commercialization of novel technologies that transform the care of patients with cardiovascular disease. The Company is focused on its intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Built on a balloon catheter platform, the IVL technology uses lithotripsy to disrupt both superficial and deep vascular calcium., while minimizing soft tissue injury, and an integrated angioplasty balloon to dilate blockages at low pressures, restoring blood flow. Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD.

1,468

Medical Equipment & Supplies

Health Care

Identifier

ISIN

US82489T1043

Primary Ticker

SWAV
Join the conversation
Sign upLogin